Cyclosporine from twice to single daily dosing: impact on renal function, mortality, and graft loss.
Bianco
P D
PD
Hospital São Paulo, Unioversidadc Federal de São Paulo, São Paulo, Brazil.
Silva
H T
HT
Boni
R
R
Machado
P G P
PG
Pacheco-Silva
A
A
Pestana
J O M
JO
D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors; D017211:Treatment Failure
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine